Results 251 to 260 of about 280,561 (284)

Dexamethasone: intravitreal implant.

Prescrire international, 2011
Macular oedema is one of the complications of retinal vein occlusion. About half of the patients recover spontaneously within 3 to 6 months. There is currently no drug that improves outcome. An intravitreal implant delivering 0.7 mg of dexamethasone has been authorised for the treatment of macular oedema in this setting. Clinical assessment is based on
openaire   +1 more source

Intravitreal dexamethasone implants for non‐infectious uveitis

Clinical & Experimental Ophthalmology, 2019
AbstractImportanceInflammatory‐mediated cystoid macular oedema (CMO) is the most common inflammatory‐mediated threat to vision in non‐infectious uveitis (NIU). Corticosteroid therapy is the cornerstone to the management of CMO in NIU. Sustained‐release dexamethasone (DEX) implant devices provide localized therapy.BackgroundThe authors present a series ...
Matthew McCartney, Peter McCluskey, Sophia Zagora   +2 more
openaire   +2 more sources

Comparative Ocular Pharmacokinetics of Dexamethasone Implants in Rabbits

Journal of Ocular Pharmacology and Therapeutics
Purpose: Dexamethasone eye implant has been used to treat macular edema and non-infectious uveitis. To date, its ocular pharmacokinetics are not fully characterized, and the development of generic preparations is in progress, as the patent of the original brand expires soon.
Jihyun, Won, Juhyung, Kang, Wonku, Kang
openaire   +2 more sources

Dexamethasone Implant in Pediatric Uveitis

Ophthalmology, 2012
Taylor, SRJ, Tomkins-Netzer, O, Joshi, L, Morarji, J, McLoone, E, Lightman, S   +5 more
openaire   +3 more sources

Dexamethasone Implants into the Crystalline Lens

European Journal of Ophthalmology, 2015
Julio González, Martín-Moro, Jesús Zarallo, Gallardo, Inmaculada Lozano, Escobar, Rosario Cobo, Soriano   +3 more
openaire   +2 more sources

Macular Hole Closure With Intravitreal Dexamethasone Implant

Ophthalmic Surgery, Lasers and Imaging Retina, 2023
Arsalan A, Ali, Ashkan M, Abbey
openaire   +2 more sources

Dexamethasone Intravitreal Implant During Phacoemulsification

Ophthalmology, 2013
Aniruddha, Agarwal, Vishali, Gupta, Jagat, Ram, Amod, Gupta   +3 more
openaire   +2 more sources

Subkonjuktivale Dexamethason-Implantation

Klinische Monatsblätter für Augenheilkunde
Louise Massia Menkene, Clara Eileen Englisch, Warda Darwisch, Peter Szurman, Annekatrin Rickmann   +4 more
openaire   +2 more sources

Inadvertent Subconjunctival Injection of a Dexamethasone Implant

JAMA Ophthalmology, 2017
Jean-Remi, Fenolland, Mickael, Sigaux, Jean-Marie, Giraud   +2 more
openaire   +2 more sources

Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema

Patient Preference and Adherence, 2023
Vincenzo Scorcia, Giulia Coco, Giuseppe Giannaccare   +2 more
exaly